Age and Hypercholesterolemia Predict Long-Term Neuropathy Risk in T2DM Read more about Age and Hypercholesterolemia Predict Long-Term Neuropathy Risk in T2DM
Fixed-Dose Combination Therapy Enhances Glycemic and Renal Outcomes in T2DM With CKD Read more about Fixed-Dose Combination Therapy Enhances Glycemic and Renal Outcomes in T2DM With CKD
Simple Anthropometric Indicators Reveal Early Vascular Aging Risk in Type 1 Diabetes Read more about Simple Anthropometric Indicators Reveal Early Vascular Aging Risk in Type 1 Diabetes
Normal Glucose Rate-of-Change Characterized Using CGM Data From Healthy Adults Read more about Normal Glucose Rate-of-Change Characterized Using CGM Data From Healthy Adults
Tirzepatide Leads Once-Weekly GLP-1 Class in Glycemic and Weight Outcomes Read more about Tirzepatide Leads Once-Weekly GLP-1 Class in Glycemic and Weight Outcomes
Second-Generation AID Improves HbA1c Without Reducing Psychosocial Burden in T1DM Tags hBA1c Read more about Second-Generation AID Improves HbA1c Without Reducing Psychosocial Burden in T1DM
GLP-1 Receptor Agonists Provide Consistent Cardiovascular and Renal Benefit Across Drug Class Read more about GLP-1 Receptor Agonists Provide Consistent Cardiovascular and Renal Benefit Across Drug Class
SGLT2 Inhibitors Improve Outcomes in CKD Regardless of Diabetes or Albuminuria Severity Tags SGLT-2 Inhibitor Read more about SGLT2 Inhibitors Improve Outcomes in CKD Regardless of Diabetes or Albuminuria Severity
Combination Exercise and Electrotherapy Reduce Pain but Not Functional Outcomes in DPN Tags Diabetic Neuropathy Read more about Combination Exercise and Electrotherapy Reduce Pain but Not Functional Outcomes in DPN
Ipragliflozin–Insulin Combination Reduces Severe Hypoglycemia With No Rise in Diabetic Ketoacidosis Read more about Ipragliflozin–Insulin Combination Reduces Severe Hypoglycemia With No Rise in Diabetic Ketoacidosis
